Melissa A. Edeling

Peter Doherty Institute — Australia

Medicine · Health Sciences

23h-index3.2kcitations49works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(15), Viral Infections and Vectors(11), SARS-CoV-2 and COVID-19 Research(10), Cellular transport and secretion(7), Malaria Research and Control(5)

Publications49 total

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
npj Vaccines·2026Open Access
Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles
Analytical Chemistry·2025· 1 cited
Adenovirus vectors can infect mouse megakaryocytes – implications for vaccine-induced thrombosis/thrombocytopenia
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Development of Methods to Produce SARS CoV‐2 Virus‐Like Particles at Scale
Biotechnology and Bioengineering·2025· 3 citedOpen Access
Development of methods to purify SARS CoV-2 Virus-like particles at scale
2024
Preclinical evaluation of a cross-protective ß-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
2024· 1 citedOpen Access
Epitope Mapping of Japanese Encephalitis Virus Neutralizing Antibodies by Native Mass Spectrometry and Hydrogen/Deuterium Exchange
Biomolecules·2024· 4 citedOpen Access
Immune imprinting of SARS-CoV-2 responses: changing first immune impressions
mSphere·2024· 11 citedOpen Access
Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
Organoids·2024· 11 citedOpen Access
Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59
SSRN Electronic Journal·2024Open Access
Cutting Edge: PDGF-DD Binding to NKp44 Costimulates TLR9 Signaling and Proinflammatory Cytokine Secretion in Human Plasmacytoid Dendritic Cells
The Journal of Immunology·2023· 6 cited
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
Frontiers in Microbiology·2023· 15 citedOpen Access
A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses
Frontiers in Immunology·2022· 16 citedOpen Access
Levels of Circulating NS1 Impact West Nile Virus Spread to the Brain
Journal of Virology·2021· 27 citedOpen Access
Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
UNC Libraries·2020Open Access
Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy
Nature Communications·2020· 53 citedOpen Access
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
Science Immunology·2019· 80 cited
Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus
mBio·2018· 43 citedOpen Access
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
Cell·2017· 278 citedOpen Access
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress
Cell·2015· 212 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Daved H. Fremont(17), Michael Diamond(14), Joseph Torresi(10), Linda Earnest(9), Ashley Huey Yiing Yap(9), David J. Owen(7), Jason Roberts(7), Dhiraj Hans(7), Kimberly A. Dowd(6), Syd Johnson(6), Theodore C. Pierson(6), Christopher A. Nelson(6), Jennifer L. Martin(6), Dale I. Godfrey(6), Simon Collett(6), Julio Carrera Montoya(6), Chinn Yi Wong(6), Jamie Mumford(5), Steven Rockman(5), S. Kyle Austin(4)